Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatment.
about
Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivoSB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in ratsChronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol.Bright-light therapy in the treatment of mood disorders.Therapeutic potential of serotonin antagonists in depressive disorders.Recent developments in the psychobiology and pharmacotherapy of depression: optimising existing treatments and novel approaches for the future.Contribution of sleep research to the development of new antidepressants.The complex role of sleep in adolescent depression.Physical activity and sleep among midlife women with vasomotor symptoms.Depression and cardiovascular health care costs among women with suspected myocardial ischemia: prospective results from the WISE (Women's Ischemia Syndrome Evaluation) Study.Internet gaming addiction, problematic use of the internet, and sleep problems: a systematic review.Trauma exposure and sleep: using a rodent model to understand sleep function in PTSD.The relationship between insomnia and depressive symptoms: genuine or artifact?Psychometric Properties of the Korean Versions of Three Sleep Evaluation Questionnaires.Insomnia in somatoform pain disorder: sleep laboratory studies on differences to controls and acute effects of trazodone, evaluated by the Somnolyzer 24 x 7 and the Siesta database.The relationship between depression, daytime napping, daytime dysfunction, and snoring in 0.5 million Chinese populations: exploring the effects of socio-economic status and age.CBT-I and HT-I group therapy for adults with insomnia in comparison to those with insomnia and comorbid depression - a pilot study
P2860
Q24647996-9994D83C-2DE5-4C73-BEBE-5CADA9F23FF8Q24672651-8D832560-14BB-4D43-8FAB-CDB314780885Q34118309-31CFDE6D-8447-45A6-B627-465140D92A63Q34205597-512995AA-D225-48B8-B488-78ACBF915F2EQ34581475-F7FB1B63-4B54-4928-9B97-34E1F36FBFF7Q35040802-082669B0-2DAD-4E76-A526-CD43181E0260Q36370226-0943E768-6946-4416-8B3D-B9D143B80F82Q36709553-E32101B8-19B2-434C-AFC9-B69740E049EAQ36983050-03D0BBFF-D630-4535-9DA7-29CEA3A7EDFDQ37316049-FE2FBBED-7DEA-4333-B26A-411B7BB7133FQ38195237-C1B2BE45-4328-4921-8FD5-DB16EE3D1E39Q38195544-D81E086E-2F29-4336-9AE0-D91CF9C79749Q42683283-EE1416DB-54BE-4585-B395-41F820AA762CQ44270737-46A55D3F-2059-4B6B-A772-2749290BD94CQ46443978-C695F075-1963-4632-BEB3-4F4C7D584A93Q55340487-42F9CBE7-065F-4F43-909A-AAE1CF40862FQ57071350-3F5DFFAC-EB3D-4336-B757-C151CDF711A6
P2860
Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatment.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Depression and sleep disorders ...... and pharmacological treatment.
@ast
Depression and sleep disorders ...... and pharmacological treatment.
@en
Depression and sleep disorders ...... and pharmacological treatment.
@nl
type
label
Depression and sleep disorders ...... and pharmacological treatment.
@ast
Depression and sleep disorders ...... and pharmacological treatment.
@en
Depression and sleep disorders ...... and pharmacological treatment.
@nl
prefLabel
Depression and sleep disorders ...... and pharmacological treatment.
@ast
Depression and sleep disorders ...... and pharmacological treatment.
@en
Depression and sleep disorders ...... and pharmacological treatment.
@nl
P2093
P356
P1433
P1476
Depression and sleep disorders ...... and pharmacological treatment.
@en
P2093
Armitage R
Brunello N
Feinberg I
Holsboer-Trachsler E
Linkowski P
Mendelson WB
Mendlewicz J
P304
P356
10.1159/000026680
P577
2000-01-01T00:00:00Z